Debut Plus

537.6

+2.94 +0.55%

17 Jul 2026

NSE Listed · Pharmaceuticals

Amrutajan Health Ltd. (AMRUTANJAN)

Volume: 102Avg Vol 1W: 11,956Avg Vol 1M: 60,73752W Range:486790.95
Key Ratios
Checked 4h ago
Market Cap₹1,536 Cr
Current Price₹537.6
Previous Close₹534.66
High / Low (52w)₹790.95 / ₹486
Volume102
Avg Vol (1W)11,956
Avg Vol (1M)60,737
Stock P/E23.82
Book Value₹128.06
Dividend Yield92%
ROE17.42%
ROA11.38%
Revenue (TTM)
Revenue Growth12.11%
Profit Margin11.52%
Total Debt₹0 Cr
Shares Outstanding3 Cr
Face Value₹1
EPS (TTM)₹22.31
P/B4.15
Debt / Equity0.02
50 DMA₹541.46
200 DMA₹550.8
Day change+0.55%
Price Chart
537.6 21.24% · 1Y
7134943.6L
2025-11-25
2026-07-17

20-day avg volume: 57K shares

Pros
  • Healthy return on equity of 17.4%.
  • Pays a dividend yield of 92.0%.
  • Company is almost debt-free.
  • Revenue grew 12% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹84 Cr₹110 Cr₹123 Cr₹135 Cr₹94 Cr₹118 Cr₹141 Cr₹150 Cr
EBITDA₹6 Cr₹16 Cr₹26 Cr₹21 Cr₹11 Cr₹19 Cr₹28 Cr₹29 Cr
Net Profit₹5 Cr₹12 Cr₹19 Cr₹15 Cr₹8 Cr₹14 Cr₹19 Cr₹16 Cr
EPS
Profit & Loss (Annual)
MetricMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Revenue₹110 Cr₹148 Cr₹142 Cr₹145 Cr₹171 Cr₹192 Cr
EBITDA₹16 Cr₹19 Cr₹18 Cr₹21 Cr₹25 Cr₹33 Cr
Net Profit₹10 Cr₹10 Cr₹10 Cr₹12 Cr₹15 Cr₹21 Cr
EPS33.732.476.928.5110.3114.08
Balance Sheet
MetricMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Total Assets₹157 Cr₹124 Cr₹124 Cr₹120 Cr₹124 Cr₹140 Cr
Total Liabilities₹55 Cr₹47 Cr₹42 Cr₹31 Cr₹29 Cr₹32 Cr
Equity₹101 Cr₹77 Cr₹82 Cr₹89 Cr₹95 Cr₹109 Cr
Total Debt
Cash Flow
MetricMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Operating₹10 Cr₹9 Cr₹14 Cr₹25 Cr₹28 Cr₹32 Cr
Investing₹-29 Cr₹14 Cr₹8 Cr₹16 Cr₹-5 Cr₹4 Cr
Financing₹20 Cr₹-27 Cr₹-14 Cr₹-14 Cr₹-12 Cr₹-13 Cr
Free Cash Flow₹10 Cr₹9 Cr₹14 Cr₹25 Cr₹28 Cr₹32 Cr
Shareholding
Promoter 46.52% Institutions 14.72% Public 38.76%
Efficiency & Working Capital
ROCE21.9%
Interest Coverage75.3
Dividend Payout
Debtor Days51 d
Inventory Days17 d
Payable Days17 d
Cash Conversion Cycle51 d
Working Capital Days68 d
Shareholding Details

As of 2026-06-30

Promoter46.5%
FII2.4%
DII12.3%
Institutions14.7%
Public38.8%
Promoter Pledge0%
No. of Shareholders45,135
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters50.6%50.6%50.6%50.6%46.5%46.5%46.5%46.5%46.5%46.5%46.5%46.5%
FIIs0.7%0.8%1.4%1.5%2.3%2.3%2.3%2.4%2.4%2.3%2.2%2.4%
DIIs7.1%6.9%7.3%7.3%10.6%11.1%11.4%12.7%12.9%13%12.7%12.3%
Public41.6%41.7%40.7%40.5%40.5%40.1%39.8%38.4%38.2%38.2%38.6%38.8%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders72,00268,40462,66457,16954,53653,85651,67449,43147,95446,67545,80545,135
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Goodhealth Holdings Private LimitedShareholding of Promoter and Promoter Group20.2%58,25,803
Sambhuprasad SivalenkaShareholding of Promoter and Promoter Group10.3%29,90,730
Ramaa Prabhakar ArikirevulaShareholding of Promoter and Promoter Group4.7%13,71,530
Dsp Small Cap FundPublic Shareholding3.8%10,98,167
Sambhu Prasad SivalenkaShareholding of Promoter and Promoter Group3.6%10,40,171
Ramaa Prabhakar ArikirevulaShareholding of Promoter and Promoter Group3%8,72,535
Carnelian Bharat Amritkaal Fund .Public Shareholding3%8,60,403
Ramalingam GantiShareholding of Promoter and Promoter Group2.5%7,30,640
Amulya Kamakshi Priya ArikirevulaShareholding of Promoter and Promoter Group2.1%6,16,781
Icici Prudential Fmcg FundPublic Shareholding2%5,80,411
Dipak Kanayalal ShahPublic Shareholding1.1%3,25,000
Carnelian Structural Shift FundPublic Shareholding1.1%3,15,000
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Sambhu Prasad Sivalenka00%2026-06-30
Ramaa Prabhakar Arikirevula00%2026-06-30
Amulya Kamakshi Priya Arikirevula00%2026-06-30
Goodhealth Holdings Private Limited00%2026-06-30
Sambhuprasad Sivalenka00%2026-06-30
Ramaa Prabhakar Arikirevula00%2026-06-30
Ramalingam Ganti00%2026-06-30
Dsp Small Cap Fund00%2026-06-30
Icici Prudential Fmcg Fund00%2026-06-30
Carnelian Bharat Amritkaal Fund .00%2026-06-30
Carnelian Structural Shift Fund00%2026-06-30
Dipak Kanayalal Shah00%2026-06-30
Board of Directors
NameDesignationYear
S SambhuprasadChairman / Executive Director / M D / Promoter2025
Ramaa Prabhakar ArikirevulaNon-Exec & Non-Independent Dir2025
G RaghavanNon-Exec & Non-Independent Dir2025
V RajaIndependent Non Exe. Director2025
Muralidharan SwayambunathanIndependent Non Exe. Director2025
Meena Lochani RaghunathanIndependent Non Exe. Director2025
V NagarajIndependent Non Exe. Director2025
GAGAN PREET SINGHCS / Compliance Officer / General Manager - Legal2025
Segments — Product
SegmentRevenueShare
OTC Products₹290 Cr64.2%
Women's Hygiene₹124 Cr27.4%
Beverages₹36 Cr8.1%
Others₹1 Cr0.3%
Segments — Geography
RegionRevenueShare
India₹442 Cr98.2%
Rest of the world₹8 Cr1.8%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1533
Corporate Actions
TypeDateValueRemark
dividend2026-02-06₹1 (100%)Interim 2
dividend2025-11-18₹1 (100%)Interim 1
dividend2025-09-16₹2.6 (260%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000437
2025000437
2025000437
Insider / Designated-Person Trades

30 recent disclosure(s)

S JeyakanthDisposal · 1,400
Nageswaramma Private TrustDisposal · 3,40,275
Nageswaramma Private TrustDisposal · 8,32,725
Amulya Kamakshi Priya ArikirevulaAcquisition · 6,16,781
RAMAA P ARIKIREVULAAcquisition · 2,64,335
S SAMBHU PRASAD EXECUTOR TO THE ESTATE OF S RAMAYAMMADisposal · 22,54,790
Substantial Acquisitions (SAST)

12 disclosure(s)

Market27/09/2024 · 3,40,275
Market26/09/2024 · 8,32,725
Transmission12/06/2024 · 36,530
Transmission28/05/2024 ·
Transmission02/05/2024 · 4,420
Transmission02/05/2024 · 4,420
Company Information
Incorporated1936
ChairmanS Sambhuprasad
AuditorB S R & Co LLP
Investor Email[email protected]; customercare@amrutanjan.
🌐 www.amrutanjan.com

📍 New 103 Old 42-45 LuzChurch Rd, Mylapore, Chennai, Tamil Nadu, 600004

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search